The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The Forum on Drug Discovery, Development, and Translation provides a neutral platform for dialogue and collaboration among thought leaders in government, industry, academia, consortia, foundations, ...

The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

The U.S. Food and Drug Administration (FDA) issued its third Patient-Focused Drug Development (PFDD) guidance titled, “Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments ...

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors, and the general public. Researchers have ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

When companies file hundreds of patents for a single drug, affordable versions can remain out of reach for years. pilli/iStock via Getty Images Plus Pharmaceutical innovation saves lives. But not ...